India to force drugmakers to upgrade plants after fatal cough syrup crisis

India has denied drugmakers more time to upgrade manufacturing facilities. This decision follows the deaths of at least 24 children from contaminated cough syrup. The government mandated World Health Organization standards after similar incidents abroad. Despite pleas from smaller firms, officials are firm on the deadline.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/jZH0vhU
via IFTTT